Akeso Biopharma
Zhongshan · Founded 2012
About Akeso Biopharma
The company has built a global level of bio-pharmaceutical research and development and industrialization platform; established for cancer, autoimmune diseases, inflammation and cardiovascular disease of the rich product line. The scale of the company's platform, hardware and software facilities, the number of new drug product lines, R & D team in the country are the same industry-leading level. Kang Fang biological has been with the international and domestic listed pharmaceutical companies to establish a cooperative relationship, the joint development of innovative antibodies to new drugs, is a strategic cooperation in the form of development of new drugs in the forerunner.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $921.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: hkg:9926
- Website: akesobio.com
- Phone: 0760-8987 3998
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/akeso-biopharma-108898 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.